SI2111401T1 - 4-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer - Google Patents

4-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer

Info

Publication number
SI2111401T1
SI2111401T1 SI200730558T SI200730558T SI2111401T1 SI 2111401 T1 SI2111401 T1 SI 2111401T1 SI 200730558 T SI200730558 T SI 200730558T SI 200730558 T SI200730558 T SI 200730558T SI 2111401 T1 SI2111401 T1 SI 2111401T1
Authority
SI
Slovenia
Prior art keywords
fluorophenoxy
methylpyridine
pyrazol
prodrugs
carboxamide
Prior art date
Application number
SI200730558T
Other languages
Slovenian (sl)
Inventor
Roger Smith
Dhanapalan Nagarathnam
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Priority claimed from PCT/US2007/088365 external-priority patent/WO2008079968A1/en
Publication of SI2111401T1 publication Critical patent/SI2111401T1/en

Links

SI200730558T 2006-12-20 2007-12-20 4-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer SI2111401T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87583006P 2006-12-20 2006-12-20
US98677307P 2007-11-09 2007-11-09
PCT/US2007/088365 WO2008079968A1 (en) 2006-12-20 2007-12-20 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
EP07865924A EP2111401B1 (en) 2006-12-20 2007-12-20 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer

Publications (1)

Publication Number Publication Date
SI2111401T1 true SI2111401T1 (en) 2011-05-31

Family

ID=42260491

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730558T SI2111401T1 (en) 2006-12-20 2007-12-20 4-{4-[3 tert butyl-1-[3-(hydroxymethyl) phenyl]-1h- pyrazol-5-yl} carbamoyl)-amino]-3-fluorophenoxy}-n- methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer

Country Status (3)

Country Link
ES (1) ES2357915T3 (en)
SI (1) SI2111401T1 (en)
ZA (1) ZA200904658B (en)

Also Published As

Publication number Publication date
ZA200904658B (en) 2010-04-28
ES2357915T3 (en) 2011-05-03

Similar Documents

Publication Publication Date Title
IL199403A0 (en) 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1h-pyrazol-5-yl}carbamoyl)-amino]-3-fluorophenoxy}-n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
HK1216100A1 (en) 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro- 2-methylpropan-2-yl)isoxazol-3-yl)urea as raf kinase modulator in the treatment of cancer diseases raf 1-(3-(67--4- ))-3-(5-(111--2--2-)-3-)
IL199673A0 (en) 5-(1,3,4- oxadiazol-2-yl)-1h-indazole and 5-(1,3,4 thiadiazol-2-yl)-1h-indazole derivatives as sgk inhibitors for the treatment of diabetes
CY2016015I1 (en) AZETIDINES AS MEK INHIBITORS FOR THE THERAPEUTIC TREATMENT OF MULTIPLIARY DISEASES
HK1124048A1 (en) 4-(phenylamino)-6-oxo-1, 6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
IL236518A0 (en) Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
ZA200804030B (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)benzamides and the salts thereof
MY150702A (en) Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
NO20081554L (en) Isoindollide compounds and compositions comprising the same, and their use
MX2008016134A (en) Phenol derivatives for the treatment of respiratory diseases.
IL206470A (en) 2-amino-1-((phosphonooxy)methyl)-3-(3-((4-((2-pyridinyloxy)methyl)phenyl)methyl)-5-isoxazolyl)-pyridinium and pharmaceutical composition comprising the same
IL202505A (en) 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, medicaments comprising them and use thereof
DK2497500T3 (en) Gene therapy for spinal muscle atrophy
PT2383271E (en) Aminoquinolones as gsk-3 inhibitors
IL236519A0 (en) Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
HRP20150104T1 (en) N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer
PL1871399T3 (en) Use of lecithin as a medicament for treating psoriasis
WO2008011478A3 (en) Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
IL179346A0 (en) 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
MX2010003989A (en) Composition 064.
WO2008079972A3 (en) 4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
EP3920898A4 (en) Methods and compositions for treating sleep apnea
NO20080133L (en) Azolopyridin-2-one derivatives such as lipase and phospholipase inhibitors